Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

The delay in meeting with the FDA clearly caught the CEO off guard who had reported November11 they would be meeting in December to discuss with FDA in advancing the clinical development of Brilacidin for ABSSSI as well as Prurisol for treatment of psoriasis. Even though their face to face meeting has been delayed it should happen soon. Brilacidin was given QIDP approval as reported Dec8 which includes fast track and priority review. Brilacidin performed very well in phase2a&2b which showed a one time dose as good or better then 7 day dose of daptomycin in treatment of ABSSSI. Investors get skiddish or impatient sell move on then come back. It will be back up even higher soon. Also cancer drug Kevetrin in phase1 testing was reported to show efficacy against metastasis ovarian cancer as reported in one patient. All good IMO.